Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Medicale (MCLE) EBIT (2020 - 2025)

Historic EBIT for Medicale (MCLE) over the last 6 years, with Q3 2025 value amounting to -$8654.0.

  • Medicale's EBIT rose 4420.01% to -$8654.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$34007.0, marking a year-over-year increase of 3783.79%. This contributed to the annual value of -$33493.0 for FY2025, which is 3877.75% up from last year.
  • According to the latest figures from Q3 2025, Medicale's EBIT is -$8654.0, which was up 4420.01% from -$3575.0 recorded in Q2 2025.
  • Medicale's 5-year EBIT high stood at -$3575.0 for Q2 2025, and its period low was -$19307.0 during Q4 2023.
  • Its 5-year average for EBIT is -$9747.5, with a median of -$8595.5 in 2023.
  • Its EBIT has fluctuated over the past 5 years, first crashed by 12156.3% in 2023, then soared by 6150.95% in 2025.
  • Medicale's EBIT (Quarter) stood at -$18096.0 in 2021, then soared by 51.85% to -$8714.0 in 2022, then plummeted by 121.56% to -$19307.0 in 2023, then rose by 19.67% to -$15509.0 in 2024, then skyrocketed by 44.2% to -$8654.0 in 2025.
  • Its EBIT was -$8654.0 in Q3 2025, compared to -$3575.0 in Q2 2025 and -$6269.0 in Q1 2025.